Acadia pharmaceuticals appoints kevin r. oliver, ph.d.

San diego--(business wire)--acadia pharmaceuticals inc. (nasdaq: acad) announced today the appointment of dr. kevin r. oliver as senior vice president, chief business officer, effective july 10, 2023. dr. oliver will oversee all business development functions and will serve as a member of the company's executive management committee, reporting to steve davis, president and chief executive officer of acadia. “we are pleased to announce kevin's appointment to lead our business development and par.
ACAD Ratings Summary
ACAD Quant Ranking